countered "John Carter" bomb (trading +2%) Blue Nile rebounded from negative surprise last qtr with sales increase & positive view (trading +5%) Demand Media soared 20% on better than expected ql report as revs up & boosted 2012 outlook Glaxo to begin hostile offer for Human Genome Sciences (HGS1) at $13